RE:Biotech-Roundup: Sirona Biochem, Paion, Atossa Genetics, Biogoogle translater German -> English:
After a streaky race of the year many eyes have been concentrating on the investor risk, but also often so lucrative biotech sector again. Values such as Sirona Biochem (WKN: A0RM6R) Paion (WKN: A0B65S) or Atossa Genetics (WKN: A1J79S) are more than ever in the focus. The Biodel share (WKN: A1JZU5) is now on the radar.
Since our first report on Sirona Biochem (WKN: A0RM6R) from 2014. A lot has happened. The highly innovative technology platform of Canadians arouses more and more interest of large companies in the cosmetics and pharmaceutical industry. At the time of our initial presentation a Sirona shares only cost about 8 euro cents, now it is trading at almost 14 cents.
In recent days, pulling sales price at Sirona again noticeably. With a current Video Post Sirona addressed specifically German speaking investors. The prospect of timely royalties should keep the interest in the stock high. Also rumored repeatedly of an impending partnership with one billion consolidated. Rapid price gains could be limited by any outstanding stock options initially, in the medium term the Sirona paper should, however, take on new highs in attack.
https://www.sharedeals.de/2016/02/biotech-roundup-sirona-biochem-paion-atossa-genetics-biodel/